Form 6-K ChowChow Cloud Internati For: Aug 26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-42839
ChowChow Cloud International Holdings Limited
(Exact name of registrant as specified in its charter)
Unit 03, 23/F, Aitken Vanson Centre,
No. 61 Hoi Yuen Road, Kwun Tong
Kowloon, Hong Kong
+852 3461 3788
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
ChowChow Cloud International Holdings Limited (NYSE American: CHOW) (the “Company”) today announced that it will hold an extraordinary general meeting of the shareholders on September 14, 2026 (the “2026 EGM”).
The 2026 EGM will be held on September 14, 2026, at 10:00 a.m., local time at 8/F, Kwok Kee Group Centre, 107 How Ming Street, Kwun Tong, Kowloon, Hong Kong. The matters to be voted on at the 2026 EGM are described in the notice and proxy statement furnished as Exhibit 99.1 to this Form 6-K filed with the U.S. Securities and Exchange Commission on August 26, 2026. Shareholders of record at the close of business on August 27, 2026 (the “Record Date”) will be eligible to vote at this meeting.
In connection with the 2026 EGM of the Shareholders of the Company, the Company hereby furnishes the following documents:
Exhibits Index
| 1 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: August 26, 2026 | ||
| ChowChow Cloud International Holdings Limited | ||
| By: | /s/ Yee Kar Wing | |
| Name: | Yee Kar Wing | |
| Title: | Chief Executive Officer | |
| 2 |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NetworkNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) to Present KROS-101 Research at Discovery on Target Conference
- The report on the implementation of mandatory non-competitive tender offer was received
- NetworkNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Reports Annual and Special Meeting Results, Legal Name Change Effective Oct. 1
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share